Can leukocytosis foresee hysterectomy for placenta previa?

Aim: The frequency of placenta previa (PP) is increasingly rising due to the increase in caesarean ratio. The aim of this study isto investigate the role of the white blood cell (WBC) in the preoperatively taken complete blood specimen in foreseeing whetherhysterectomy will be performed or not in patients with placenta previa totalis.Materials and Methods:Two hundred fifty-seven (257) patients who experienced caesarean due to placenta previa totalis (PPT) inOndokuz Mayis University between 2010 and 2018 had been surveyed retrospectively. The results of the preoperative CompleteBlood Count (CBC) of the Placenta PreviaTotalis (PPT) patients in which either hysterectomy was applied or not, demographiccharacteristics, other follow-up and treatment results were accessed via system records and file surveys. The primary outcome is therole of preoperative White Blood Cell (WBC) levels in predicting hysterectomy,Results: WBC median values in the pre-operative complete blood specimen of the patients with placenta previa totalis demonstratedifference between the patients with hysterectomy and those without hysterectomy. While the median value was as 9.7 109/L in thepatients who could be recovered with treatments apart from hysterectomy, this was obtained as 11.3109/L in the patients in whichhysterectomy was applied (p=0.007).Conclusion: Increase in WBC in the pre-operative blood specimen of the patients with diagnosis of Placenta Previa Totalis may beguiding whether hysterectomy will be applied or not.

PDF

___

1. Abuhamad A. Morbidly adherent placenta. Semin Perinatol 2013;37:359-64.
2. Wehrum MJ, Buhimschi IA, Salafia C, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 2011;204:411.e1-411.e11.
3. Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta. Am J Obstet Gynecol 2010;203:430-9.
4. Silver RM. Placenta accreta: we can do better!. BJOG: An Int J Obst Gynaecol 2016;123:1356-6
5. Shamshirsaz AA., Fox KA., Erfani, H. et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 2017;216:612-e1.
6. Lim BH, Palacios-Jaraquemada JM. The morbidly adherent placenta—a continuing diagnostic and management challenge. BJOG: An Int J Obst Gynaecol 2015;122:1673-3.
7. Lyell DJ, Faucett AM., Baer RJ. et all. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol 2015;35:570.
8. Dreux S, Salomon LJ, Muller F et al. Second-trimester maternal serum markers and placenta accreta. Prenatal diagnosis 2012;32:1010-2.
9. Lurie S, Rahamim E., Piper I. et al. Total and differential leukocyte counts percentiles in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2008;136:16-9.
10. Lurie S., Weiner E., Golan A et al. Total and differential leukocyte count percentiles in healthy singleton term women during the first stage of labor. Gynecol Obstet Invest 2014;78:251-4.
11. Schwartz J and Weiss ST. Host and environmental factors influencing the peripheral blood leukocyte count. Am J Epidemiol 1991;134:1402-9.
12. Mercelina-Roumans PEAM, Ubachs JMH, Van Wersch JWJ. Leucocyte count and leucocyte differential in smoking and non-smoking females during pregnancy. Eur J Obstet Gynecol Reprod Biol 1994;55:169-73.
13. Arbib N, Aviram A, Gabbay Ben-Ziv R, et al. The effect of labor and delivery on white blood cell count. J Matern Fetal Neonatal Med. 2016;29:2904-8.
14. Owiredu WK, Osakunor DN, Turpin CA et all. Laboratory prediction of primary postpartum haemorrhage: a comparative cohort study. BMC Pregnancy Childbirth. 2016;16: 17.
15. Rush D. Nutrition and maternal mortality in the developing world. Am J Clin Nutr 2000;7:212-40.